BRIEF published on 02/11/2026 at 09:05, 3 months 5 days ago Aiforia Technologies Oyj's Innovative Path to Profitability Profitability Medical Imaging Aiforia Technologies Vision Transformer Foundation Engine
PRESS RELEASE published on 02/11/2026 at 09:00, 3 months 5 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj advances with new Foundation Engine technology for medical imaging, aiming for improved accuracy and scalability. Analyst recommends BUY with €3.80 target price Medical Imaging Scalability Accuracy Aiforia Technologies Oyj Foundation Engine
BRIEF published on 12/12/2025 at 09:05, 5 months 4 days ago Aiforia Technologies Strengthens Liquidity with Share Issuance Liquidity Share Issuance Cost Savings Growth Projections Aiforia Technologies
PRESS RELEASE published on 12/12/2025 at 09:00, 5 months 4 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj successfully completes directed share issuance, raising €4.2m to ease liquidity constraints. Company aims for sustainable cash generation with reduced operating expenses Cash Generation Operating Expenses Liquidity Constraints Aiforia Technologies Oyj Directed Share Issuance
BRIEF published on 10/23/2025 at 09:05, 6 months 24 days ago Aiforia Technologies Oyj Positioned as Pathology AI Leader Market Growth Diagnostic Accuracy Pathology AI Aiforia Technologies NuWays AG Rating
PRESS RELEASE published on 10/23/2025 at 09:00, 6 months 24 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj receives Buy recommendation for disrupting pathology with AI technology, leading in cancer diagnostics with AI-powered platform for faster, more accurate diagnoses AI-powered Platform Buy Recommendation Cancer Diagnostics Aiforia Technologies Oyj Pathology AI Technology
Published on 05/16/2026 at 01:15, 21 hours 26 minutes ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 22 hours 41 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 23 hours 31 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 23 hours 41 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 6 hours 32 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 2 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 4 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 1 day 5 hours ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 05/15/2026 at 15:08, 1 day 7 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/13/2026 at 17:45, 3 days 4 hours ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 3 days 4 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 3 days 5 hours ago Report on share repurchases from 6 to 12 May 2026
